Skip to main content

Table 1 Patients’ characteristics stratified by alcohol consumption classification at baseline

From: Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection?

Baseline characteristics Abstainers (N = 3422) Moderate (N = 2279) Hazardous (N = 637) Total (N = 6338)
Gender, n(%)
 Male 2363 (69.1%) 1954 (85.7%) 567 (89.0%) 4884 (77.1%)
 Female 1059 (30.9%) 325 (14.3%) 70 (11.0%) 1454 (22.9%)
Age, years
 Median (IQR) 38 (31, 47) 37 (30, 45) 41 (34, 49) 38 (31, 46)
Mode of HIV Transmission, n(%)
 PWID 367 (10.7%) 250 (11.0%) 114 (17.9%) 731 (11.5%)
 Homosexual contacts 1317 (38.5%) 1124 (49.3%) 222 (34.9%) 2663 (42.0%)
 Heterosexual contacts 1517 (44.3%) 757 (33.2%) 269 (42.2%) 2543 (40.1%)
 Other/Unknown 221 (6.5%) 148 (6.5%) 32 (5.0%) 401 (6.3%)
Nationality, n(%)
 Italian 2572 (75.2%) 1915 (84.0%) 516 (81.0%) 5003 (78.9%)
Region, n(%)
 North 1577 (46.1%) 1144 (50.2%) 382 (60.0%) 3103 (49.0%)
 Center 1366 (39.9%) 866 (38.0%) 217 (34.1%) 2449 (38.6%)
 South 479 (14.0%) 269 (11.8%) 38 (6.0%) 786 (12.4%)
AIDS diagnosis, n(%)
 Yes 336 (9.8%) 156 (6.8%) 43 (6.8%) 535 (8.4%)
CD4 count cells/mm3, n(%)
 ≤ 300 1156 (33.8%) 580 (25.4%) 172 (27.0%) 1908 (30.1%)
 301–500 810 (23.7%) 593 (26.0%) 166 (26.1%) 1569 (24.8%)
 ≥ 501 1035 (30.2%) 861 (37.8%) 216 (33.9%) 2112 (33.3%)
 Unknown 421 (12.3%) 245 (10.8%) 83 (13.0%) 749 (11.8%)
HIV-RNA viral load, n(%)
 ≤ 5000 605 (17.7%) 389 (17.1%) 114 (17.9%) 1108 (17.5%)
 5001–10,000 208 (6.1%) 172 (7.5%) 48 (7.5%) 428 (6.8%)
 10,001–100,000 1222 (35.7%) 922 (40.5%) 231 (36.3%) 2375 (37.5%)
 ≥ 100,001 1025 (30.0%) 567 (24.9%) 179 (28.1%) 1771 (27.9%)
 Unknown 362 (10.6%) 229 (10.0%) 65 (10.2%) 656 (10.4%)
Smoking, n(%)
 No 2201 (64.3%) 924 (40.5%) 188 (29.5%) 3313 (52.3%)
 Yes 1092 (31.9%) 1268 (55.6%) 413 (64.8%) 2773 (43.8%)
 Unknown 129 (3.8%) 87 (3.8%) 36 (5.7%) 252 (4.0%)
Hepatitis B, n(%)
 Yes 107 (3.1%) 59 (2.6%) 25 (3.9%) 191 (3.0%)
HCV Infection, n(%)
 Negative 2366 (69.1%) 1549 (68.0%) 409 (64.2%) 4324 (68.2%)
 Positive 410 (12.0%) 250 (11.0%) 119 (18.7%) 779 (12.3%)
 Not tested 646 (18.9%) 480 (21.1%) 109 (17.1%) 1235 (19.5%)
Calendar year, n(%)
 2002–2006 473 (13.8%) 313 (13.7%) 69 (10.8%) 855 (13.5%)
 2007–2012 1113 (32.5%) 671 (29.4%) 218 (34.2%) 2002 (31.6%)
 2013–2016 1836 (53.7%) 1295 (56.8%) 350 (54.9%) 3481 (54.9%)
Follow-up (months)
 Median (IQR) 26.5 (7.4, 57.1) 23.4 (4.8, 53.5) 25.6 (5.6, 54.8) 25.2 (6.1, 55.6)